Entrada Therapeutics, Inc.

SEC 4 · Filed

0001873392-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 10, 2026

Sale by Dowden Nathan J

Security
Common Stock
Code
S
Shares
11,894
Price per share
13.05Reported 13.0476
Structured facts
{
  "code": "S",
  "date": "2026-03-10",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2025.",
    "F3": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
  },
  "owners": [
    {
      "cik": "0001873392",
      "name": "Dowden Nathan J",
      "roles": [
        "officer"
      ],
      "title": "President \u0026 COO"
    }
  ],
  "ownership": "D",
  "post_shares": "198588",
  "price": "13.0476",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "11894",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 9, 2026

Sale by Dowden Nathan J

Security
Common Stock
Code
S
Shares
3,116
Price per share
13.02Reported 13.024
Structured facts
{
  "code": "S",
  "date": "2026-03-09",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2025.",
    "F2": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
  },
  "owners": [
    {
      "cik": "0001873392",
      "name": "Dowden Nathan J",
      "roles": [
        "officer"
      ],
      "title": "President \u0026 COO"
    }
  ],
  "ownership": "D",
  "post_shares": "210482",
  "price": "13.024",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "3116",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}